Cardiosense, Inc.: FDA clearances and approvals

Cardiosense, Inc. has 1 FDA 510(k) clearance (first 2025, latest 2025), plus 1 De Novo decision, across 2 product codes in 1 review panel. Median 510(k) review time: 246 days.

510(k) clearances per year

YearClearancesMedian review days
20251246
20260—

Review time against the same product codes

Since 2017, Cardiosense, Inc.'s cleared 510(k)s took a median 246 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 246 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
DXRBallistocardiograph11
SIFSoftware Device System For Estimation Of Cardiac Pressures10

Review panels

Most recent Cardiosense, Inc. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K243566CardioTag™DXR2025-07-22246

PMA and De Novo decisions

NumberPathwayDeviceDecision date
DEN250057De NovoSoftware Device System For Estimation Of Cardiac Pressures2026-05-22

Recalls

openFDA lists no recalls under a recalling firm named Cardiosense, Inc..

Recalling firms are matched to this company by name only (same normalization as the applicant), so related entities that recall under another name are not counted.

Frequently asked questions

How many FDA 510(k) clearances does Cardiosense, Inc. have?

Cardiosense, Inc. has 1 FDA 510(k) clearance (first 2025, latest 2025), plus 1 De Novo decision, across 2 product codes in 1 review panel.

How long does FDA take to clear Cardiosense, Inc.'s 510(k)s?

The median time from FDA receipt to decision across Cardiosense, Inc.'s cleared 510(k)s is 246 days.

What devices does Cardiosense, Inc. make?

Its most frequent FDA product codes are DXR (Ballistocardiograph, 1); SIF (Software Device System For Estimation Of Cardiac Pressures, 1).

Has Cardiosense, Inc. had device recalls?

openFDA lists no recalls under a recalling firm name matching Cardiosense, Inc. Related entities may recall under other names.

Next steps

Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Companies are grouped by FDA applicant name with punctuation and legal suffixes removed. Review days run from FDA receipt to decision. Not regulatory advice.

All FDA device companies · FDA product code lookup